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| INTRODUCTION
Respiratory syncytial virus (RSV) is the virus most commonly associated with bronchiolitis affecting infants and young children. [1] [2] [3] can induce lower respiratory tract illness (LRTI), which encompasses bronchiolitis and viral pneumonia can lead to death in severe cases. 4 All children have been infected with RSV by the age of 2 years, and nearly half of these cases will experience recurrent infections. 5 A large proportion of young patients with RSV bronchiolitis have recurrent episodes of lower airway obstruction, which may continue for years after the acute infection has resolved. 2 Several prospective birth cohort studies have reported that early-life RSV-associated LRTI plays an important causative role in the pathogenesis of recurrent wheezing and asthma. [5] [6] [7] However, current therapeutic options are limited to supportive treatment focusing on fluid and respiratory maintenance, and there is a need for more widely available and cost-effective preventative measures. 8 In addition, the mechanism by which RSV evades host defenses is not fully understood. 2 Clarifying RSV pathogenesis in humans and developing prophylactic or therapeutic strategies for RSV infection in the respiratory tract is required.
Recently, chitinase 3-like 1 protein (CHI3L1) (YKL-40 in humans and breast regression protein [BRP]-39 in mice) has been implicated in the development of asthma. Circulating levels of YKL-40 were increased in patients with asthma, which was correlated with disease severity.
9
CHI3L1 variants affected serum YKL-40 levels and influenced asthma status and lung function. 10 BRP-39 was identified as an important regulator of allergic responses and tissue remodeling in mice. 11 CHI3L1 has also been linked to other types of chronic lung inflammation 12, 13 and acute lung injury. 14 However, the role of CHI3L1 in viral respiratory infection has not been previously investigated.
In this study, we hypothesized that CHI3L1 is involved in airway inflammation induced by RSV infection. To investigate this possibility, we measured YKL-40 in human nasopharyngeal aspirates (NPAs) from hospitalized children presenting with acute respiratory symptoms, and compared the immune responses induced by RSV in wildtype (WT) and BRP-39 knockout (KO) mice. We found that RSV infection induced IL-13-dominant immune responses in a murine model and that CHI3L1/BRP-39 may enhance airway hyperresponsiveness (AHR), inflammatory cell recruitment, and mucus production in RSV-infected mice. Moreover, treatment with anti-CHI3L1 antibody attenuated RSV-induced airway inflammation and Th2 cytokine production in RSV-infected WT mice, suggesting that CHI3L1 is a therapeutic candidate for the treatment of RSV-associated LRTI.
| METHODS

| Study population
From December in 2015 to February in 2018, nasopharyngeal aspirates were collected from children hospitalized at Severance
G R A P H I C A L A B S T R A C T
Respiratory syncytial virus infection induces increased expression of BRP-39 by macrophages and epithelial cells that is related to Th2 inflammation. A lack of BRP-39 attenuates RSV-induced airway inflammation and IL-13 responses. BRP-39 is an important regulator of RSV infection and suggested as a potential therapeutic target for RSV-related respiratory illness.
Children's Hospital due to acute respiratory symptoms such as coughing, wheezing, or tachypnea. For NPA collection, a sterile suction catheter was inserted into the oropharynx through the nostril and gentle suction was applied using an electric suction pump. 15 After washing the catheter with normal saline, samples were placed into viral transport medium and kept at −70°C until further pro- 
| Preparation of RSV stock
The RSV A2 strain was propagated in HEp-2 cells (American Type Culture Collection, Manassas, VA, USA) and harvested on days 4 postinfection (dpi) when the cytopathic effect in infected cells was maximal. The final titer was also established in HEp-2 cells and determined with the standard plaque assay. 
| Measurement of AHR in mice
Lung resistance was measured at 7 dpi as previously described. 
| Quantification of mucus production
Muc5AC protein was measured by ELISA, as previously described by Lee et al. Standards and negative controls were included in each PCR assay.
Customized TaqMan primer-probe sets for the RSV N gene, a wellconserved region of RSV A2, were used. 20 Gene expression was quantified using a StepOne Real-Time PCR system (Applied Biosystems).
| Flow cytometry
After whole lung from mouse prepared followed as previously described, 18 isolated cells were incubated with Fc block antibody | 687
antibody (eBio13A; eBioscience). Samples were analyzed on an LSR II flow cytometer (BD Biosciences) using FlowJo software (Tree Star, Ashland, OR, USA).
| Assessment of macrophage activation
To assess alternative macrophage activation, alveolar macrophages in BALF and lung cells were examined for surface expression of CD206. Arginase activity in BALF and lung lysates was measured using the QuantiChrom Arginase Assay kit (BioAssay Systems, Hayward, CA, USA) according to the manufacturer's instructions. 21 
| Anti-CHI3L1 antibody treatment in WT mice
WT RSV-infected mice were administered a single 50-μg dose of anti-CHI3L1 antibody (AF2649) (R&D Systems) 22 or vehicle via the intraperitoneal route 24 hours after RSV infection. Mice were euthanized on 7 dpi, and inflammation and immune responses induced by RSV infection were analyzed. Changes in BRP-39 expression were also noted. Lungs harvested from each group were stained with H&E or PAS to evaluate inflammation and mucus production, respectively. Jolla, CA, USA). P < 0.05 was considered statistically significant.
| Statistical analysis
| RESULTS
| YKL-40 expression is increased in children with RSV infection
To investigate the relationship between CHI3L1 and RSV infection, YKL-40 levels in NPA samples from hospitalized children were measured ( Figure 1A ). The clinical characteristics of the subjects are summarized in Table S1 . Between the 43 patients with RSV infection and 12 patients without any confirmed pathogens, there were no significant differences in age, gender, duration of admission, past history, and laboratory findings. Children with confirmed RSV infection showed higher scores for acute respiratory symptoms at the time of admission than the control group (P < 0.001). Children with RSV infection had higher YKL-40 ( Figure 1B ) and IL-13 (Figure 1C ) levels than control subjects. In patients with RSV infection, YKL-40 level was positively correlated with symptom score (Figure 1D) and IL-13 level in NPA ( Figure 1E ). These data suggest CHI3L1 expression is increased by RSV infection and is correlated with the severity of symptoms in children. Moreover, CHI3L1
expression may be related to IL-13 expression and IL-13-induced airway inflammation.
| BRP-39 deficiency attenuates RSV-induced airway inflammation without affecting viral load
We compared BRP-39 expression between control and RSV-infected mice on 7 dpi. As in children with RSV infection, BRP-39 levels in the lungs and BALF were increased in RSV-infected as compared to control mice (Figure 2A-D) . Induction of BRP-39 was prominent in airway epithelial cells ( Figure 2E ) and alveolar macrophages (Figure 2E-G) .
In WT mice, RSV infection caused inflammatory changes of weight loss and increased AHR in the methacholine challenge test as well as increased inflammatory cell recruitment in BALF on 7 dpi ( Figure 3A-C) . Total cell counts and neutrophil, lymphocyte, and eosinophil counts were increased by RSV infection ( Figure 3C ).
But all of these inductive inflammations were less severe in infected BRP-39 KO mice rather than WT RSV mice ( Figure 3A-C) .
A histological analysis revealed that tissue inflammation ( Figure 3D) and mucus production ( Figure 3E ,F) were also decreased in RSVinfected BRP-39 null mice. There was no difference in viral load after RSV infection between WT and BRP-39 KO mice ( Figure 3G ).
These data indicate that loss of BRP-39 could attenuate airway inflammation induced by RSV infection, without significant changes in viral load.
| BRP-39 regulates Th2 inflammation induced by RSV infection
Given that Th2-biased inflammation is a major consequence of RSV infection, we hypothesized that BRP-39 might affect Th2 inflamma- inflammation and especially IL-13 expression in RSV-infected mice while having no effect on the production of other inflammatory cytokines.
| BRP-39 regulates M2 macrophage activation
We next investigated the mechanisms by which BRP-39 drives Th2 inflammation and AHR during RSV infection in mice. Since alternatively activated (M2) macrophages are known to affect Th2 inflammation during RSV infection and are associated with BRP-39 and allergic inflammation, we evaluated macrophage activation and found that the number of M2 macrophages in BALF and lung cells was increased in infected mice ( Figure 5A,C) . Moreover, M2 macrophage arginase 1 activity in BALF ( Figure 5B ) and lung lysates ( Figure 5D ) was increased in infected WT and BRP-39 KO mice, although it was >50% lower in the latter. These results indicate that BRP-39 regulates the accumulation and activation of M2 macrophages and induces IL-13-dominant Th2 inflammation during RSV infection. Figure 6G ) and mucus production ( Figure 6H ) were also decreased by the antibody treatment, which had no effect on viral load in the lungs ( Figure 6I ). Th2 cytokine levels were also decreased in Mucus production evaluated by periodic acidSchiff staining (E) and ELISA (F). RSV infection increased mucus production in WT but not BRP-39 KO mice. G, Loss of BRP-39 had no effect on lung viral load at 1, 3, 5, 7, 10, and 14 dpi. Values in A-D represent mean ± SD of at least three independent experiments. n.s., not significant. In panels A and D, *P < 0.05, **P < 0.01, ***P < 0.001 for WT PBS vs WT RSV and + P < 0.05, ++ P < 0.01, +++ P < 0.001 for WT RSV vs KO RSV. In panel B, ***P < 0.001 for WT RSV vs WT PBS and KO RSV KIM ET AL.
| CHI3L1 neutralization has therapeutic effects on RSV-induced inflammation
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F I G U R E 4 Breast regression protein-39 (BRP-39) regulates activation of Th2 inflammation. Lung tissue from each group was analyzed by flow cytometry. A, CD4+ and CD8+ T cell counts were higher in the wild-type (WT) respiratory syncytial virus (RSV) group and CD4+ T cell counts were lower in BRP-39 knockout (KO) mice. B, DCs were detected by staining with anti-CD11b, -CD11c, and -MHC II antibodies. In the absence of BRP-39, the number of DCs was decreased relative to RSV-infected WT mice. C, Eosinophil counts were higher in the lungs of RSV-infected WT as compared to BRP-39 KO mice. D-F, Th2 cytokine mRNA levels were determined by RT-PCR. IL-13 level was elevated in RSV-infected WT mice, whereas Th2 cytokine expression was not significantly increased by RSV infection in BRP-39 KO mice. G, IL-13 level in bronchoalveolar lavage fluid (BALF) was increased in WT RSV mice, as determined by ELISA. H, IL-13 expression was evaluated in CD4+ T cells in BALF. I, IFN-γ production was increased in BALF after RSV infection in both WT and BRP-39 KO mice, as determined using a cytokine bead array. n.d., not detected; n.s., not significant. *P < 0.05, **P < 0.01, Moreover, in vivo neutralization of CHI3L1 using an anti-CHI3L1
antibody could decrease the severity of IL-13-dominant airway inflammation during RSV infection.
Chitinase-like proteins (CLPs) are structurally similar to chitinases but lack enzymatic activity. Recent studies have shown that mammalian CLPs present at sites of inflammation and tissue remodeling do trigger immune responses and attract eosinophils and T cells, even in the case of parasitic infection. 23, 24 In allergic responses, CHI3L1 is a key regulator of Th2 inflammation, M2 macrophage differentiation, and Th2 cell and macrophage apoptosis/cell death. BRP-39 null mice showed significant defects in antigen-induced Th2 inflammation and IL-13-induced inflammation and remodeling. 11, 24 In humans, the relationship between YKL-40 and asthma development has also been demonstrated. 9, 10, 25, 26 CHI3L1 is known to bind to IL-13Rα2 composing a multimeric complex with IL-13, 27 but the mechanism by which CHI3L1/BRP-39/YKL-40 mediates downstream effects is poorly understood, and few studies have investigated the relationship between CHI3L1 and viral respiratory infections that induce Th2 inflammation or asthma.
Respiratory syncytial virus is known as the major cause of severe LRTI in infants and young children, 2 and a causative agent in the pathogenesis of recurrent wheezing and asthma. [5] [6] [7] It is possible that a relationship exists between early-life RSV LRTI and late-onset asthma, but it is unclear whether RSV is a risk factor or a marker of predisposition to asthma. Identifying molecules involved in the RSVasthma pathway can provide a basis for preventing asthma develop- , and breast regression protein-39 levels (E,F) were evaluated. G, Airway inflammation and mucus production were assessed by H&E and periodic acid-Schiff staining, respectively. H, Mucus production was also measured by ELISA. I, There was no difference in viral load among groups. J-L, IL-13 was the most prominent Th2 cytokine in BALF induced by RSV infection and decreased by anti-CHI3L1 antibody treatment. M-O, Th2 cytokine mRNA levels in lungs were also decreased by treatment with anti-CHI3L1 antibody in RSV-infected mice, with IL-13 levels showing the greatest change. Data from three mice per group are plotted as mean ± SD. n.s., not significant. In panels B and C, *P < 0.05, **P < 0.01, ***P < 0. Th1, Th2, and Th17, was proven to be also as a potent stimulator of BRP-9 in fibrotic diseases. 44 IL-18 production could be also induced by RSV infection. 45 During RSV infection, increased IL-18 could be thought to stimulate epithelial cells to produce BRP-39 and enhance Th2 inflammation. In addition, the expression of IL-13Rα2-a receptor for CHI3L1 during effector responses 27 was not investigated. 
